The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure
- PMID: 35726110
- DOI: 10.1007/s10741-022-10254-6
The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure
Abstract
There is an expanding body of research on the bidirectional relationship of the human gut microbiome and cardiovascular disease, including heart failure (HF). Researchers are examining the microbiome and gut metabolites, primarily trimethylamine-N-oxide (TMAO), to understand clinically observed outcomes. This systematic review explored the current state of the science on the evaluation and testing of the gut biome in persons with HF. Using electronic search methods of Medline, Embase, CINAHL, and Web of Science, until December 2021, we identified 511 HF biome investigations between 2014 and 2021. Of the 30 studies included in the review, six were 16S rRNA and nineteen TMAO, and three both TMAO and 16S rRNA, and two bacterial cultures. A limited range of study designs were represented, the majority involving single cohorts (n = 10) and comparing individuals with HF to controls (n = 15). Patients with HF had less biodiversity in fecal samples compared to controls. TMAO is associated with age, BNP, eGFR, HF severity, and poor outcomes including hospitalizations and mortality. Inconsistent across studies was the ability of TMAO to predict HF development, the independent prognostic value of TMAO when controlling for renal indices, and the relationship of TMAO to LVEF and CRP. Gut microbiome dysbiosis is associated with HF diagnosis, disease severity, and prognostication related to hospitalizations and mortality. Gut microbiome research in patients with HF is developing. Further longitudinal and multi-centered studies are required to inform interventions to promote clinical decision-making and improved patient outcomes.
Keywords: Dysbiosis; Gut flora; Gut metabolite; Gut microbiome; Heart failure; TMAO; Trimethylamine-N-oxide.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Exploring the Microbiome in Heart Failure.Curr Heart Fail Rep. 2016 Apr;13(2):103-9. doi: 10.1007/s11897-016-0285-9. Curr Heart Fail Rep. 2016. PMID: 26886380 Free PMC article. Review.
-
Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.Int J Cardiol. 2021 Sep 1;338:138-142. doi: 10.1016/j.ijcard.2021.06.003. Epub 2021 Jun 5. Int J Cardiol. 2021. PMID: 34102245
-
Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.Circ Heart Fail. 2021 Jun;14(6):e007909. doi: 10.1161/CIRCHEARTFAILURE.120.007909. Epub 2021 Jun 15. Circ Heart Fail. 2021. PMID: 34129361 Free PMC article.
-
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.J Intern Med. 2015 Jun;277(6):717-26. doi: 10.1111/joim.12328. Epub 2014 Dec 1. J Intern Med. 2015. PMID: 25382824
-
Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?Curr Heart Fail Rep. 2021 Apr;18(2):23-32. doi: 10.1007/s11897-021-00503-4. Epub 2021 Feb 9. Curr Heart Fail Rep. 2021. PMID: 33559845 Review.
Cited by
-
Trends in gut-heart axis and heart failure research (1993-2023): A bibliometric and visual analysis.Heliyon. 2024 Feb 7;10(4):e25995. doi: 10.1016/j.heliyon.2024.e25995. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38404792 Free PMC article.
-
Capillary rarefaction: a missing link in renal and cardiovascular disease?Angiogenesis. 2024 Feb;27(1):23-35. doi: 10.1007/s10456-023-09883-8. Epub 2023 Jun 16. Angiogenesis. 2024. PMID: 37326760 Review.
-
Combined analysis of plasma metabolome and intestinal microbiome sequencing to explore jiashen prescription and its potential role in changing intestine-heart axis and effect on chronic heart failure.Front Cardiovasc Med. 2023 Mar 10;10:1147438. doi: 10.3389/fcvm.2023.1147438. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36970332 Free PMC article.
-
Shenfu injection improves isoproterenol-induced heart failure in rats by modulating co-metabolism and regulating the trimethylamine-N-oxide - inflammation axis.Front Pharmacol. 2024 Jun 20;15:1412300. doi: 10.3389/fphar.2024.1412300. eCollection 2024. Front Pharmacol. 2024. PMID: 38966553 Free PMC article.
-
Exploring the association between cardiovascular health and bowel health.Sci Rep. 2024 May 23;14(1):11819. doi: 10.1038/s41598-024-62715-7. Sci Rep. 2024. PMID: 38783080 Free PMC article.
References
-
- Bozkurt B, Coats AJS, Tsutsui H et al (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Euro J Heart Fail 23(3):352–380. https://doi.org/10.1002/ejhf.211549 - DOI
-
- Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MS (2022) Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation 26:CIR0000000000001052
-
- Virani SS, Alonso A, Aparicio HJ et al (2021) Heart disease and stroke statistics—2021 update: a report from the American Heart Association. Circulation 143(8):e254–e743. https://doi.org/10.1161/CIR0000000000000950 - DOI - PubMed
-
- Lippi G, Sanchis-Gomar F (2020) Global epidemiology and future trends of heart failure. AME Med J 5:15. https://doi.org/10.21037/amj.2020.03.03
-
- Kitai T, Wilson Tang WHW (2018) Gut microbiota in cardiovascular disease and heart failure. Clin Sci 132(1):85–91. https://doi.org/10.1042/CS20171090 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous